Fady Emad's Contact Details

Fady Emad's Company Details

Glenmark Pharmaceuticals Ltd.

Mumbai, Maharashtra, India • 3900 Employees
Pharmaceuticals

Glenmark Generics Limited aims to be a global integrated Generic and API leader. The Company currently markets finished dose formulations in USA, Europe, and Argentina and has Active Pharmaceutical Ingredients (APIs) presence in over 80 countries through an established group of subsidiaries, marketing front-ends and offices in India and select overseas locations. GGL has a strong base in Formulation development with teams operating out of laboratories in India and Argentina. The Company has a state-of-the-art manufacturing plant at Goa, India that has been inspected by US FDA, TPD (Canada), MHRA, UK and many other overseas regulatory authorities. GGL also markets over 45 APIs to more than 80 countries across the world and had over 35 US DMFs filed. Glenmark's API division possesses strong, dedicated process research capabilities and a dedicated team of scientists equipped with the best analytical tools and a sophisticated information centre. Currently, GGL has three API manufacturing plants in India of which its plant at Ankhleshwar has been inspected by USFDA and several other international regulatory bodies. The Generics business has been built over the last 5 years, End to End vertically integrated into the generic market, GGL is a subsidiary of Glenmark Pharmaceuticals Ltd. GGL's US subsidiary Glenmark Generics Inc GGL's EU subsidiary Glenmark Generics (Europe) Ltd Glenmark acquired the Argentinean company Servycal S.A